Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Malaria vaccine has indirect protective effects

Aug. 21, 2019

Preclinical data presented for the novel re-engineered lupus autoantibody PAT-DX1

Aug. 20, 2019

First-in-human results for the chlamydia vaccine candidate CTH-522

Aug. 20, 2019

Pharmacokinetics and safety data presented from phase I study of EA-230

Aug. 16, 2019

Kezar Life Sciences initiates PRESIDIO and MARINA phase II studies of KZR-616

Aug. 14, 2019

First patient dosed in phase Ib/IIa PREVAIL study of PRV-3279

Aug. 9, 2019

Novel T-cell subtype predicts risk of anaphylactic shock

Aug. 8, 2019

Wild moms are good for offspring microbiome

Aug. 8, 2019

Dosing starts in phase I study of DNL-758

Aug. 6, 2019

Cancer research leads to pregnancy insights

Aug. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...